Motilal Oswal's research report on Equitas Small Finance
Equitas Small Finance Bank (EQUITASB) reported in-line earnings for 2QFY24 at INR1.98b (up 70% YoY/3.6% QoQ), because of healthy NII growth (up 26% YoY/3% QoQ) and controlled provisions (in line) aided by reversal of INR230m on account of the sale to ARC. AUM growth was steady at 37% YoY/ 5.5% to INR312b, driven by healthy traction across most of the segments (barring MSE finance). Management expects credit growth to remain robust at 25-30%. Deposits growth was robust at 42% YoY/ 11% QoQ, led by faster growth in TDs, while CASA mix deteriorated 480bp QoQ to 33.6%. The cost of funds thus rose 27bp QoQ to 7.2% leading to 33bp drop in NIMs to 8.4% (in line). Slippages were elevated mainly due to higher slippages from the CV segment, while healthy recoveries and ARC sale enabled 48bp/21bp QoQ decline in GNPA/NNPA ratio to 2.3%/1.0%. PCR was largely stable at 57.7%.
Outlook
We raise our FY25E earnings by ~5% and estimate EQUITASB to deliver an FY25E RoA/RoE of 2.0%/16%. Maintain BUY with a TP of INR115 (premised on 1.9x FY25E BV).
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Discover the latest Business News, Budget 2025 News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!